- Identification of a prognostic immune signature for cervical cancer to predict survival and response to immune checkpoint inhibitors
Si Yang et al, 2019, OncoImmunology CrossRef - The Relevant Participation of Prolactin in the Genesis and Progression of Gynecological Cancers
Adrián Ramírez-de-Arellano et al, 2021, Frontiers in Endocrinology CrossRef - 4SC-202 exerts an anti-tumor effect in cervical cancer by targeting PRLR signaling pathway
Huijuan Zhang et al, 2022, Journal of Molecular Histology CrossRef